Charles M. Baum serves as Executive at Mirati Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Charles M. Baum has executed 106 insider transactions totaling $49.5M, demonstrating a bearish approach to their equity position. Their most recent transaction on Jun 14, 2016 involved purchasing 20,000 shares valued at $141.0K.
Charles M. Baum currently holds 78,600 shares of Mirati Therapeutics, Inc. (MRTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Charles M. Baum has been a net seller of MRTX stock. They have purchased $225.8K and sold $49.3M worth of shares.
Charles M. Baum's most recent insider trade was on Jun 14, 2016, when they purchased 20,000 shares at $7.05 per share.
Get notified when new Form 4 filings are submitted
| $3.86 |
| Discretionary |
| May 8, 2015 | ARRY | $184.5K | Sale | 25,000 | $7.38 | Discretionary |
| Jul 25, 2014 | MRTX | $100.0K | Option Exercise | 11,778 | $8.49 | Discretionary |
| Feb 19, 2014 | MRTX | $100.0K | Option Exercise | 11,778 | $8.49 | Discretionary |
| Nov 26, 2013 | MRTX | $84.8K | Purchase | 5,000 | $16.96 | Discretionary |